MoneyWorks4Me

Dr Lal Path labs informs about investor presentation

09 Feb 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr Lal Path labs has informed about the Corporate Presentation of the Company, which the Company proposes to share with analysts/investors.

The above information is a part of company’s filings submitted to BSE.

Peers